States must accept vetted out-of-state doctors for Medicaid kids

What it does

This bill requires states to streamline how they enroll out-of-state healthcare providers in Medicaid and CHIP (children's health insurance). Instead of imposing their own screening requirements, states must accept providers who have already been vetted by Medicare or another state's Medicaid program and have a low fraud risk. Eligible out-of-state providers get a 5-year enrollment period, reducing barriers for children to access care from providers outside their home state.

Why we flagged it

The bill's core function is to remove state-level enrollment barriers for out-of-state providers in Medicaid/CHIP, expanding geographic access to care for children. It is a regulatory streamlining measure, not a funding or commemorative bill.

What the text implies

• Out-of-state providers may face reduced state-level oversight compared to in-state providers, potentially creating inconsistent quality or compliance standards across state lines.
• The 5-year enrollment lock-in may reduce states' ability to quickly remove underperforming providers, though exclusion for fraud/abuse remains available.
• Smaller or rural states with limited local provider networks may see increased out-migration of patient revenue to larger neighboring states' providers.
• The 3-year implementation delay allows states time to prepare but may create a gap period where access disparities persist.

Who it affects

Children and families gain easier access to out-of-state specialists and providers without additional bureaucratic delays. The bill reduces redundant screening by leveraging existing Medicare and state vetting, lowering administrative friction while maintaining fraud safeguards through prior screening.

Who stands to gain

• healthcare providers in high-demand specialties
• telehealth and multi-state provider networks
• pediatric specialists in border regions

Named in the bill

Medicaid, CHIP, Medicare, Social Security Act Section 1902, Social Security Act Section 2107, HHS (implied regulatory authority), State Medicaid agencies

Where it stands

45 cosponsors: 26 Democrats, 19 Republicans.

• Feb 26, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• Feb 26, 2025 — Referred to Senate Committee on Finance · Congress.gov: “Read twice and referred to the Committee on Finance”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

28 lobbying clients named this bill on 36 disclosure filings across 3 quarters, Dec 2025 to Jun 2026. Those filings disclosed $8,545,749 in lobbying spend. A filing names 8 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 98% of bills with at least one filing.

Chuck Grassley, the sponsor, reported $49,167 in PAC receipts in the 2026 cycle.

• American Cancer Society Cancer Action Network Inc — $2,380,000 on 1 filing
• National Association of Children's Hospitals (n.a.c.h.) — $1,370,000 on 1 filing
• Acadia Pharmaceuticals — $1,290,000 on 2 filings
• Blood Cancer United (fka the Leukemia & Lymphoma Society) — $590,000 on 1 filing
• The Children's Hospital of Philadelphia — $520,000 on 2 filings

Lobbying Disclosure Act filings through Jul 22, 2026. A filing shows who paid to lobby on a bill it names, not what changed.